| 1 | VIPR2
|
| Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway
|
| Asano S, Ono A, Sakamoto K, Hayata-Takano A, Nakazawa T, Tanimoto K, Hashimoto H, Ago Y.
|
| Peptides. Mar;161:170940. doi: 10.1016/j.peptides.2023.170940. Epub 2023 Jan 2. 2023
|
| 2 | VIPR2
|
| The myopia susceptibility locus vasoactive intestinal peptide receptor 2 (VIPR2) contains variants with opposite effects
|
| Leung KH, Luo S, Kwarteng R, Chen SG, Yap MKH, Huang CL, Yip SP.
|
| Sci Rep. Dec 3;9(1):18165. doi: 10.1038/s41598-019-54619-8. 2019
|
| 3 | CFH, VIPR2
|
| CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy
|
| Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Ahn J, Woo SJ, Honda S, Sakurada Y, Shiragami C, Nakanishi H, Oishi A, Ooto S, Miki A; Nagahama Study Group; Iida T, Iijima H, Nakamura M, Khor CC, Wong TY, Song K, Park KH, Yamada R, Matsuda F, Tsujikawa A, Yamashiro K.
|
| Proc Natl Acad Sci U S A. Jun 12;115(24):6261-6266. doi: 10.1073/pnas.1802212115. Epub 2018 May 29. 2018
|
| 4 | CACNA1C, MRPL21, VIPR2
|
| Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma.
|
| Shi ZZ, Shang L, Jiang YY, Shi F, Xu X, Wang MR, Hao JJ.
|
| Cancer Biomark 15(6):755-61. doi: 10.3233/CBM-150517.
2015
|
| 5 | VIPR2
|
| Low-copy repeats at the human VIPR2 gene predispose to recurrent and nonrecurrent rearrangements
|
| Beri S, Bonaglia MC, Giorda R.
|
| Eur J Hum Genet. Jul;21(7):757-61. doi: 10.1038/ejhg.2012.235. Epub 2012 Oct 17. 2013
|
| 6 | SCZD29, VIPR2
|
| Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia.
|
| Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters V, Welsh DK, Craig D, Kelsoe JR, Gershon ES, Leal SM, Dell Aquila M, Morris DW, Gill M, Corvin A, Insel PA, McClellan J, King MC, Karayiorgou M, Levy DL, DeLisi LE, Sebat J.
|
| Nature 471(7339):499-503. Epub 2011 Feb 23.
2011
|
| 7 | VIP, VIPR2
|
| Activation of the VIP/VPAC2 system induces reactive astrocytosis associated with increased expression of glutamate transporters.
|
| Nishimoto M, Miyakawa H, Wada K, Furuta A.
|
| Brain Res 1383:43-53. Epub 2011 Jan 31.
2011
|
| 8 | VIP, VIPR1, VIPR2
|
| Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.
|
| Valdehita A, Bajo AM, Fernández-Martínez AB, Arenas MI, Vacas E, Valenzuela P, Ruíz-Villaespesa A, Prieto JC, Carmena MJ.
|
| Peptides 31(11):2035-45. Epub 2010 Aug 5.
2010
|
| 9 | VIP, VIPR1, VIPR2
|
| Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation.
|
| St Hilaire RC, Murthy SN, Kadowitz PJ, Jeter JR Jr.
|
| Peptides 31(8):1517-22. Epub 2010 May 7.
2010
|
| 10 | ADCYAP1R1, VIP, VIPR1, VIPR2
|
| VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.
|
| Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM.
|
| J Appl Physiol 109(1):95-100. Epub 2010 Apr 15.
2010
|
| 11 | VIP, VIPR1, VIPR2
|
| Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.
|
| Martin B, Shin YK, White CM, Ji S, Kim W, Carlson OD, Napora JK, Chadwick W, Chapter M, Waschek JA, Mattson MP, Maudsley S, Egan JM.
|
| Diabetes 59(5):1143-52. Epub 2010 Feb 11.
2010
|
| 12 | VIP, VIPR1, VIPR2
|
| Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
|
| Burian B, Storka A, Marzluf BA, Yen YC, Lambers C, Robibaro B, Vonbank K, Mosgoeller W, Petkov V.
|
| Peptides 31(4):603-8. Epub 2009 Dec 22.
2010
|
| 13 | VIP, VIPR1, VIPR2
|
| The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.
|
| Zaben M, Sheward WJ, Shtaya A, Abbosh C, Harmar AJ, Pringle AK, Gray WP.
|
| Stem Cells 27(10):2539-51.
2009
|
| 14 | VIPR1, VIPR2
|
| Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.
|
| Igarashi H, Ito T, Kuwano-Kojima M, Takayanagi R, Coy DH, Jensen RT.
|
| Pancreas 37(2):236-8. No abstract available.
2008
|
| 15 | VIP, VIPR1, VIPR2
|
| Select cognitive deficits in vasoactive intestinal peptide deficient mice.
|
| Chaudhury D, Loh DH, Dragich JM, Hagopian A, Colwell CS.
|
| BMC Neurosci 9:63.
2008
|
| 16 | VIPR1, VIPR2
|
| Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors.
|
| Bokaei PB, Ma XZ, Byczynski B, Keller J, Sakac D, Fahim S, Branch DR.
|
| Genomics 88(6):791-800. Epub 2006 Aug 24. 2006
|
| 17 | VIPR2
|
| Structure of the human VIPR2 gene for vasoactive intestinal peptide receptor type 2.
|
| Lutz EM, Shen S, Mackay M, West K, Harmar AJ.
|
| FEBS Lett 458(2):197-203 1999
|
| 18 | VIPR2
|
| Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene : a possible contributor to the holoprosencephaly 3 phenotype.
|
| Mackay M, et al.
|
| Genomics 37 : 345-353. 1996
|
| 19 | VIPR2
|
| Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.
|
| Svoboda M, et al.
|
| Biochem Biophys Res Commun 205 : 1617-1624. 1994
|
| 20 | VIPR2
|
| The VIP2 receptor : molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide.
|
| Lutz EM, et al.
|
| FEBS Lett 334 : 3-8. 1993
|